IP Verse

Zentiva Ks competitive analysis

Explore patent oppositions filed by Zentiva Ks against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026

Patent Number	Title	Applicant	Opposition Date
EP4188389	Methods Of Treating Chronic Kidney Disease With Dapagliflozin	ASTRAZENECA	Jun 17, 2026
EP3689365	Use Of Long-Acting Glp-1 Peptides	NOVO NORDISK	May 5, 2026
EP3411021	New Use Of A Combination Of Sacubitril And Valsartan	NOVARTIS	Feb 13, 2026
EP4212152	Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure	NOVARTIS	Jan 30, 2026
EP4125903	Methods For Dose Initiation Of Aripiprazole Treatments	OTSUKA PHARMACEUTICAL	Jul 9, 2025
EP3226841	Anticancer Compositions	ARAGON PHARMACEUTICALS	Jul 7, 2025
EP4321157	New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)	NOVARTIS	Jun 25, 2025
EP3090730	Novel Pharmaceutical Composition	NOVARTIS	Jan 10, 2025
EP2395968	Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A Patient	BOEHRINGER INGELHEIM	Oct 14, 2024
EP3494972	Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv Infection	VIIV HEALTHCARE	Sep 13, 2024

Discover the latest PTAB cases involving Zentiva Ks, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Zentiva Ks with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
ZENTIVA KS	44	-	-	-